532628 Sigma-AldrichVps34 Inhibitor, VPS34-IN1 - CAS 1383716-33-3 - Calbiochem
A cell-permeable, highly potent, selective, and reversible inhibitor of Vps34 activity (IC₅₀ = 25 nM).
More>> A cell-permeable, highly potent, selective, and reversible inhibitor of Vps34 activity (IC₅₀ = 25 nM). Less<<Synonyms: 1-(2-(2-Chloropyridin-4-ylamino)-4ʹ-(cyclopropylmethyl)-4,5ʹ-bipyrimidin-2ʹ-ylamino)-2-methylpropan-2-ol, Vacuolar Protein Sorting 34 Inhibitor, PIK3C3 Inhibitor
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 1383716-33-3 | C₂₁H₂₄ClN₇O |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.32628.0001 |
|
Glass bottle | 5 mg |
|
— |
| References | |
|---|---|
| References | Bago, R., et al. 2014. Biochem. J. 463, 413. |
| Product Information | |
|---|---|
| CAS number | 1383716-33-3 |
| Form | White powder |
| Hill Formula | C₂₁H₂₄ClN₇O |
| Chemical formula | C₂₁H₂₄ClN₇O |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Vps34 |
| Primary Target IC<sub>50</sub> | 25 nM using recombinant Vsp34:Vps15 complex |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 5.32628.0001 | 04055977281835 |
Documentation
Vps34 Inhibitor, VPS34-IN1 - CAS 1383716-33-3 - Calbiochem SDS
| Title |
|---|
References
| Reference overview |
|---|
| Bago, R., et al. 2014. Biochem. J. 463, 413. |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



